Terumo Corp (OTCPK:TRUMF)
$ 19.3805 -0.0185 (-0.1%) Market Cap: 28.52 Bil Enterprise Value: 28.39 Bil PE Ratio: 35.86 PB Ratio: 3.46 GF Score: 97/100

Q2 2022 Terumo Corp Earnings Call Transcript

Nov 04, 2021 / 08:00AM GMT
Release Date Price: $22.4 (+0.83%)
Naoki Muto
Terumo Corporation - Chief Accounting & Financial Officer and Executive Officer

I am the CAFO, Muto. I will now explain the second quarter results for the fiscal year ending March 2022. First, the highlights from the quarter. Sales and profit were both our highest ever. In sales revenue, demand for Cardiac and Vascular Company products made a significant recovery from COVID-19 impact. Although that company was somewhat affected by a repeated wave of COVID due to the Delta variant, the other 2 companies covered that impact.

In adjusted operating profit, a recovery in sales and product mix improvement both contributed. Expenses including SG&A, which rose slowly in the first quarter, progressed as planned in the second quarter. There is no change in the guidance for the full fiscal year, but we will raise the dividend to JPY 32 from the previous JPY 30. We anticipate a continued recovery of demand for procedures in the second half, which will bring our results into a growth pattern. However, amid what is expected to become a more concerning situation of higher freight costs due

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot